India, July 13 -- Today's top biotech gainers include Q32 Bio, following positive Phase 2 results for its hair loss treatment; Agenus, as it advances development of its colon cancer drug combination, botensilimab and balstilimab; and Shoulder Innovations, which recently raised its full-year revenue guidance, among others.
Read on.
QTTB Delivers Strong SIGNAL
Q32 Bio Inc. (QTTB) led the pack of biotech gainers on Monday, with shares soaring over 90% on the back of positive results from its Phase 2 trial of Bempikibart in patients with severe or very severe alopecia areata, dubbed SIGNAL-AA.
In Part B of the SIGNAL-AA trial, by Week 36, 40.0% of patients in the modified intent-to-treat (mITT) group and 30.3% of all enrolled patients inclu...